Jiangxi Synergy Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jiangxi Synergy Pharmaceutical Co Ltd with three other
companies in this sector in CHINA :
Lansen Pharmaceutical Holdings Limited
sales of 374.46 million Chinese Renmimbi [US$58.65 million]
of which 95%
was Specialty Pharmaceuticals),
Fujian Cosunter Pharmaceutical Co Ltd
(368.49 million Chinese Renmimbi [US$57.72 million]
of which 100%
was Medicine), and
Zhejiang Ausun Pharmaceutical Co Ltd
(409.25 million Chinese Renmimbi [US$64.10 million]
of which 34%
was Antibacterial Products).
During the second
quarter of 2021, sales at Jiangxi Synergy Pharmaceutical Co Ltd totalled
139.72 million Chinese Renmimbi.
This is a drop of 0.8%
from the 140.78 million Chinese Renmimbi in sales at the company during the second quarter in 2020.
During the first two
quarters of 2021, sales totalled 277.53 million Chinese Renmimbi, which is
than through the first two quarters of 2020.
During the year ended December of 2020, sales at
Jiangxi Synergy Pharmaceutical Co Ltd were 435.42 million Chinese Renmimbi (US$68.20 million).
increase of 5.4%
versus 2019, when the company's sales were 413.06 million Chinese Renmimbi.
Sales of Others saw an increase
that was more than double the company's growth rate: sales were up
161.8% in 2020, from
554,698.21 Chinese Renmimbi to 1.45 million Chinese Renmimbi.